A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 15,710 shares of VKTX stock, worth $664,847. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,710
Previous 8,910 76.32%
Holding current value
$664,847
Previous $472,000 110.59%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$49.84 - $70.47 $338,912 - $479,196
6,800 Added 76.32%
15,710 $994,000
Q2 2024

Aug 14, 2024

BUY
$47.39 - $80.2 $172,973 - $292,730
3,650 Added 69.39%
8,910 $472,000
Q1 2024

May 15, 2024

BUY
$17.4 - $94.5 $91,523 - $497,070
5,260 New
5,260 $431 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.25B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.